Literature DB >> 8329713

Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia.

E J Steenbergen1, O J Verhagen, E F van Leeuwen, A E von dem Borne, C E van der Schoot.   

Abstract

Acute lymphoblastic leukemia (ALL) is thought to arise from the clonal expansion of a single transformed precursor cell. However, an oligoclonal Ig heavy chain (IgH) rearrangement pattern has been observed in 30% of ALL patients and was shown to be the result of ongoing rearrangement events. The extent and nature of these ongoing rearrangement processes in individual patients has so far remained obscure. We performed a detailed analysis of leukemic VHDJH rearrangements in three children with B-precursor ALL at diagnosis and one B-lymphoid blast crisis of a child with Ph+ chronic myeloid leukemia at diagnosis and relapse. The children were selected because they presented with multiple IgH rearrangements on Southern blot analysis. Polymerase chain reaction analysis of leukemic cells from two B-precursor ALL patients showed exclusively two groups of related sequences resulting from VH gene replacement events. Most VH gene replacements involved 3' located acceptor VH genes. Analysis of cells from the other B-precursor ALL patient showed exclusively related sequences as a result of VH gene joinings to a pre-existing DJH rearrangement. In the B-lymphoid blast crisis, a single germline precursor cell had generated multiple unrelated rearrangements and additional groups of related rearrangements resulting from VH to DJH joinings. Direct proof for the VH to DJH joining mechanism was obtained by amplification of the expected preexisting DJH rearrangements. Our findings suggest that the pattern of ongoing rearrangements in an individual patient reflects the IgH rearrangement status of the precursor cell at the time of malignant transformation. Sequence analysis of VHDJH rearrangements at diagnosis may therefore allow a prediction of the reliability of complementarity determining region 3 probes for the detection of minimal residual disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329713

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  NF-κB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity.

Authors:  Katarina Ochodnicka-Mackovicova; Mahnoush Bahjat; Timon A Bloedjes; Chiel Maas; Alexander M de Bruin; Richard J Bende; Carel J M van Noesel; Jeroen E J Guikema
Journal:  Blood       Date:  2015-07-07       Impact factor: 22.113

2.  Establishment of a novel B cell clonality analysis using single-strand conformation polymorphism of immunoglobulin light chain messenger signals.

Authors:  S Shiokawa; J Nishimura; K Ohshima; N Uike; K Yamamoto
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

3.  Detection of clonality by polymerase chain reaction in childhood B-lineage acute lymphoblastic leukemia.

Authors:  D A Januszkiewicz; J S Nowak
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

Review 4.  V(H) replacement in rearranged immunoglobulin genes.

Authors:  John M Darlow; David I Stott
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

5.  Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia.

Authors:  Charles Gawad; Francois Pepin; Victoria E H Carlton; Mark Klinger; Aaron C Logan; David B Miklos; Malek Faham; Gary Dahl; Norman Lacayo
Journal:  Blood       Date:  2012-08-28       Impact factor: 22.113

6.  Gene conversion in human rearranged immunoglobulin genes.

Authors:  John M Darlow; David I Stott
Journal:  Immunogenetics       Date:  2006-05-17       Impact factor: 2.846

7.  Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia.

Authors:  Malek Faham; Jianbiao Zheng; Martin Moorhead; Victoria E H Carlton; Patricia Stow; Elaine Coustan-Smith; Ching-Hon Pui; Dario Campana
Journal:  Blood       Date:  2012-10-16       Impact factor: 22.113

8.  Determining the repertoire of IGH gene rearrangements to develop molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemia.

Authors:  Michael J Brisco; Sue Latham; Rosemary Sutton; Elizabeth Hughes; Vicki Wilczek; Katrina van Zanten; Bradley Budgen; Anita Y Bahar; Maria Malec; Pamela J Sykes; Bryone J Kuss; Keith Waters; Nicola C Venn; Jodie E Giles; Michelle Haber; Murray D Norris; Glenn M Marshall; Alexander A Morley
Journal:  J Mol Diagn       Date:  2009-03-26       Impact factor: 5.568

Review 9.  Molecular processes involved in B cell acute lymphoblastic leukaemia.

Authors:  Camille Malouf; Katrin Ottersbach
Journal:  Cell Mol Life Sci       Date:  2017-08-17       Impact factor: 9.261

Review 10.  Immune Gene Rearrangements: Unique Signatures for Tracing Physiological Lymphocytes and Leukemic Cells.

Authors:  Michaela Kotrova; Nikos Darzentas; Christiane Pott; Claudia D Baldus; Monika Brüggemann
Journal:  Genes (Basel)       Date:  2021-06-27       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.